Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases of after solid organ transplantation

The American Journal of Medicine

Volumn 86, Issue 2 C, 1989, Pages 241-244

  Pirsch, John D ^a   Stratta, Robert J ^a   Sollinger, Hans W ^a   Hafez, Gholam R ^a   D'Allesandro, Anthony M ^a   Kalayoglu, Munci ^a   Belzer, Folkert O ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; GANCICLOVIR; HYDROCORTISONE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; OKT 3; PREDNISONE;

ADULT; CASE REPORT; EPSTEIN BARR VIRUS; FATALITY; FEMALE; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CASE REPORT; FEMALE; GANCICLOVIR; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMAN; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGE; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 0024495517     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(89)90279-9     Document Type: Article

References (22)

1. The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders
2. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation
3. Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients
4. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients
5. Lymphopoliferative disorders in cardiac transplant recipients are multiclonal lymphomas
6. Reversibility of lymphomas and lymphoproliferative lesions developing under cycloporin-steroid therapy
7. Acyclovir therapy of Epstein-Barr virus induced post-transplant lymphoproliferative diseases
8. Treatment of life-threatening Epstein-Barr virus infection with acyclovir
9. Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies
10. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation
11. 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent
12. Synthesis and antiherpes simplex virus activity of 9-[(1,3dihydroxy-2-propylthio)methyl]guanine
13. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus
14. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine for cytomegalovirus replication in vitro
15. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts
16. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia
17. Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine
18. Treatment of serious cytomegalovirus infections with 9-(13-dihydroxy-2-propxymethyl)guanine in patients with AIDS and other immunodeficiencies
19. Lactic acidosis associated with Hodgkin's disease
20. Increased infections associated wtih the use of OKT3 treatment of steroid-resistant rejection in renal transplantation
21. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation
22. Epstein-Barr-virus induced lymphoproliferation